| Techn. Profiles | EU | | Offers | 4968 | | Requests | 765 | | Total (2008-2010) | 5733 |
Technology profiles visited | | Today | 2713 | | Last Week | 30878 | | April | 80669 | | March | 65212 | | February | 72684 |
| Techn. e-Alert subscribers in Switzerland, per region: | | Lake Geneva | 190 | | Mittelland French | 80 | | Mittelland German | 68 | | Northwestern | 43 | | Zurich | 89 | | Eastern | 43 | | Central | 25 | | Ticino | 41 | | Other | 68 | | Total | 647 |

The Enterprise Europe Network is funded by the European Commission via the Competitiveness and Innovation Programme (CIP). Swiss network partners are financed by the Swiss government.
| | Title of Profil | Stability and validation testing of an innovative vaccines single vial system
| | Reference | 12 GB 46P4 3PHN | | Country of origin | United Kingdom | | Offers/Requests | Request | | Entry/Update | 2012-07-06 / 2012-07-06 | | Status | This request is probably solved. Within 5 months, 90% of the requests are solved by the Enterprise Europe Network. Please contact your local EEN office to check validity! (2013-06-12) |
AbstractA Scottish device development company has commercialised a device which allows for the creation of a single vial rather than two vials which are currently needed in order to create many solutions presently in pharmaceutical, diagnostic, nutritionals fields. The company is now seeking technical cooperation partners for testing, with the purpose of conducting in-vitro experimentation to validate the stability of a novel delivery technology for Human Vaccines.
DetailsFunding has been secured for the purpose of in-vitro testing of actual vaccines within the innovative Single Vial System and for this, the Scottish company requires a testing partner. In-vitro experimentation expertise to validate the stability of a novel delivery technology for Human Vaccines is required by the company to complete Phase I studies. These Human Vaccines will preferably be from the primary areas of focus for global health such as tuberculosis and pneumonia.
Technical Specifications / Specific technical requirements:
The company is open to collaboration with any qualified Contract Research Organization (CRO) which specialises in pre-clinical vaccine testing. The need for a qualified Testing Partner is imminent and offers to provide it are welcome from any interested company.
Technology sector | - Clinical Research, Trials - Diseases - Medical Research - Medical Technology / Biomedical Engineering - Virus, Virology/Antibiotics/Bacteriology
| Cooperation type | - License Agreement - Joint further development - Testing of new applications - Adaptation to specific needs - Transfer of knowledge in new raw materials - New way to use an existing production line - Change in the currently used technologies - Absolutely novel process - Quality control
Type of partner sought: CRO
Specific area of activity of the partner: In-Vitro Testing
Task to be performed by the partner sought: In-Vitro Testing of Vaccines
| Organisation type | Industry Org. Size: < 10
|
We only react to expressions of interest in Swiss profiles and/or made by organisations based in Switzerland
Would you like to contact this organisation?
Yes
|
- You are not based in Switzerland? You are not interested in a Swiss profiles?
Find your local access point on the Network website.
- This technology profile does not fit your requirements?
You are searching for a tailor made solution?
You are interested to promote your own technology profile?
=> Contact us now!
=> In short time we can find suitable partners
Further Details |
|